Cargando…

Evaluation of the Antithrombotic Effects of Rivaroxaban and Apixaban Using the Total Thrombus-Formation Analysis System(®): In Vitro and Ex Vivo Studies

BACKGROUND: The usefulness of the Total Thrombus-Formation Analysis System(®) (T-TAS(®)) for monitoring the anticoagulant effects of non-vitamin K oral anticoagulants (NOACs) in clinical practice has been poorly addressed. METHODS: NOACs (rivaroxaban and apixaban) were added to whole blood from heal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugihara, Hidekazu, Idemoto, Yoshiaki, Kuwano, Takashi, Nagata, Yoshihisa, Morii, Joji, Sugihara, Makoto, Ogawa, Masahiro, Miura, Shin-ichiro, Saku, Keijiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087631/ https://www.ncbi.nlm.nih.gov/pubmed/27829957 http://dx.doi.org/10.14740/jocmr2773w

Ejemplares similares

Pregnancy May Affect the Attenuation of an ST Segment Elevation in the Right Precordial Leads: A Female Patient with Brugada Syndrome
por: Ideishi, Akihito, et al.
Publicado: (2019)

Gap-related Pulmonary Vein and Left Atrial Flutter Mimicking Cavotricuspid Isthmus-dependent Atrial Flutter
por: Komaki, Tomo, et al.
Publicado: (2020)

A Coronary Artery Calcium Score of Zero in Patients Who Have Undergone Coronary Computed Tomography Angiography Is Associated With Freedom From Major Adverse Cardiovascular Events
por: Shiga, Yuhei, et al.
Publicado: (2020)

Acute Myocardial Infarction in a 26-Year-Old Patient With Familial Hypercholesteremia
por: Miyayama, Takeshi, et al.
Publicado: (2016)

Postural Conversion Computed Tomography for the Diagnosis of Pneumopericardium due to Perforation by the Active Atrial Lead
por: Futami, Makito, et al.
Publicado: (2019)

Association of Arterial Pressure Volume Index With the Presence of Significantly Stenosed Coronary Vessels
por: Ueda, Takashi, et al.
Publicado: (2016)

Visit-to-Visit Variability and Seasonal Variation in Blood Pressure With Single-Pill Fixed-Dose Combinations of Angiotensin II Receptor Blocker/Calcium Channel Blocker and Angiotensin II Receptor Blocker/Diuretic in Hypertensive Patients
por: Shiga, Yuhei, et al.
Publicado: (2015)

A Continuous Murmur as the Only Clinical Sign for Complex Coronary Artery Fistulas Diagnosis
por: Imaizumi, Tomoki, et al.
Publicado: (2021)

Association Between Visit-to-Visit Variability in Blood Pressure and Cardiovascular Events in Hypertensive Patients After Successful Percutaneous Coronary Intervention
por: Gondo, Kouki, et al.
Publicado: (2015)

Depressor and Anti-Inflammatory Effects of Angiotensin II Receptor Blockers in Metabolic and/or Hypertensive Patients With Coronary Artery Disease: A Randomized, Prospective Study (DIAMOND Study)
por: Adachi, Sen, et al.
Publicado: (2016)

Associations Between High Levels of High-Density Lipoprotein Cholesterol and the Presence and Severity of Coronary Artery Disease in Patients Who Have Undergone Coronary Computed Tomography Angiography
por: Tashiro, Kohei, et al.
Publicado: (2020)

Association Between the Level of Low-Density Lipoprotein Cholesterol and Coronary Atherosclerosis in Patients Who Have Undergone Coronary Computed Tomography Angiography
por: Inoue, Hiroko, et al.
Publicado: (2021)

Measurement of rivaroxaban and apixaban in serum samples of patients
por: Harenberg, Job, et al.
Publicado: (2014)

Impact of von Willebrand factor on coronary plaque burden in coronary artery disease patients treated with statins
por: Kato, Yuta, et al.
Publicado: (2018)

Impact of the Absolute Difference in Diastolic Blood Pressure Between Arms in Patients With Coronary Artery Disease
por: Hitaka, Yuka, et al.
Publicado: (2015)

The effect of a dual or a triple antithrombotic therapy with apixaban on thrombus formation in vivo and in an ex vivo perfusion chamber model: An open-label, controlled, sequential study
por: Weisshaar, Stefan, et al.
Publicado: (2016)

The use of Apixaban for the treatment of an LV thrombus
por: Bennett, Sadie, et al.
Publicado: (2018)

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban
por: Frost, Charles, et al.
Publicado: (2014)

Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
Publicado: (2020)

Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements
por: Meihandoest, Tamana, et al.
Publicado: (2021)

Safety of apixaban and rivaroxaban compared to warfarin after cardiac surgery
por: Naik, Kushal D., et al.
Publicado: (2022)

Apixaban for oral antithrombotic therapy: is a new era coming?
por: Zhang, Yong
Publicado: (2014)

COVID-19 with essential thrombocythemia treated with apixaban for antithrombotic prophylaxis
por: Takasaki, Kazuki, et al.
Publicado: (2021)

Resolution of left atrial appendage thrombus with apixaban
por: Kawakami, Tohru, et al.
Publicado: (2013)

Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus: A Case Report
por: Seecheran, Rajeev, et al.
Publicado: (2017)

A Novel Synthesis of the Oxazolidinone Antithrombotic Agent Rivaroxaban
por: Yuan, Jianyong, et al.
Publicado: (2014)

Rivaroxaban and apixaban in orthopaedics: is there a difference in their plasma concentrations and anticoagulant effects?
por: Freyburger, Geneviève, et al.
Publicado: (2015)

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum
Publicado: (2018)

Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation
por: Kim, Paul Y., et al.
Publicado: (2018)

Real‐World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
por: Lin, Shin‐Yi, et al.
Publicado: (2019)

Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
por: Úlehlová, Jana, et al.
Publicado: (2021)

Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects
por: Ansell, Jack, et al.
Publicado: (2021)

Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures
por: Bradshaw, Paige Garber, et al.
Publicado: (2022)

In vivo evaluation of the pharmacokinetic interactions between almonertinib and rivaroxaban, almonertinib and apixaban
por: Wang, Zhi, et al.
Publicado: (2023)

Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data
por: ASLAN, Onur, et al.
Publicado: (2022)

Association between mitral annulus calcification and subtypes of heart failure rehospitalization
por: Kato, Yuta, et al.
Publicado: (2023)

Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension
por: Shiga, Yuhei, et al.
Publicado: (2017)

The Change in Body Weight During Hospitalization Predicts Mortality in Patients With Acute Decompensated Heart Failure
por: Komaki, Tomo, et al.
Publicado: (2017)

Rapid resolution of left ventricular thrombus with apixaban therapy
por: Berry, Abeer, et al.
Publicado: (2017)

Recent Patient Characteristics and Medications at Admission and Discharge in Hospitalized Patients With Heart Failure
por: Arimura, Tadaaki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hp1nrj60bu5emr28k681t8frbh